321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC)
Title:
321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC)
Author:
Roderburg, C. Gonzalez Carmona, M.A. Berres, M-L. Modest, D.P. Mohr, R. Wree, A. Venerito, M. Keitel, V. Waldschmidt, D.T. Lüdde, T. Kehmann, L.